why choose us

First received: September 28, 2023

Clinical Trial: VK2735 for Weight Management Phase 2

Study Status: Completed

Recruit Status: RECRUITING

Condition: Weight Loss

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 13-week Study of VK2735 for Weight Management in Subjects Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition

Brief Summary: This is a phase 2, 13-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ?30 kg/m2) or who are overweight (BMI ?27 kg/m2) with at least one weight-related co-morbid condition.VK2735 or matched placebo will be administered once weekly.

Read more